Global Cord Blood Corporation (OTCPK: CORB.F)
Health Care · Health Care Providers & Services · HK
$0.95
+0.11% today · -40.6% 1Y
Global Cord Blood Corporation (OTCPK: CORB.F) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $127.35M and employs 1,202 people.
Over the last twelve months the share price has lost 40.6%, trading between 0.20 and 1.75.
Tweenvest scores Global Cord Blood Corporation across four factors: quality 91/100, value 79/100, growth 68/100. Its strongest factor is quality.
CORB.F price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $127.35M
- Revenue (TTM)
- $196.10M
- P/E
- 1.46
- EPS
- 4.12
- Dividend yield
- —
- Beta (5Y)
- -0.77
- 52-week high
- $1.75
- 52-week low
- $0.20
- Avg volume (3M)
- —
- Shares outstanding
- 133.91M
- Employees
- 1,202
- Next earnings
- —
About Global Cord Blood Corporation
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.
- ISIN
- KYG393421030
- Listed since
- Jan 25, 2007
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| UnitedHealth Group IncorporatedNYSE: UNH | $357.92B | $398.76 | +2.22% |
| CVS Health CorporationNYSE: CVS | $120.36B | $94.11 | +1.17% |
| McKesson CorporationNYSE: MCK | $101.88B | $873.79 | +1.73% |
| HCA Healthcare, Inc.NYSE: HCA | $92.93B | $429.24 | +0.01% |
| Elevance Health, Inc.NYSE: ELV | $87.32B | $402.63 | +0.52% |
| The Cigna GroupNYSE: CI | $74.11B | $280.45 | +1.06% |
| Cencora, Inc.NYSE: COR | $61.78B | $323.77 | +1.80% |
| Cardinal Health, Inc.NYSE: CAH | $54.04B | $232.37 | +1.25% |
Figures last refreshed Aug 18, 2026.